We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Tissue Engineering and Cell Therapy to Grow to Over $30 Billion Global Market
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Tissue Engineering and Cell Therapy to Grow to Over $30 Billion Global Market
BusinessNewsTechnology

Tissue Engineering and Cell Therapy to Grow to Over $30 Billion Global Market

PatrickDriscoll
PatrickDriscoll
Share
3 Min Read
SHARE

The market for tissue engineering and cell therapy products is set to grow from a respectable $9.9 billion in 2011 to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall market for regenerative medicine technologies and products comprises orthopedic applications.

The market for tissue engineering and cell therapy products is set to grow from a respectable $9.9 billion in 2011 to nearly $32 billion by 2018. This figure includes bioengineered products that are themselves cells or are actively stimulating cell growth or regeneration, products that often represent a combination of biotechnology, medical device and pharmaceutical technologies. The largest segment in the overall market for regenerative medicine technologies and products comprises orthopedic applications. Other key sectors are cardiac and vascular disease, neurological diseases, diabetes, inflammatory diseases and dental decay and injury.

The clinical applications with the most rapid growth in tissue engineering and cell therapy continues to be organ transplantation and related technologies. Over the 2009–2018 period, this segment is expected to grow by roughly 46%. This unusually explosive growth is expected due to: (1) the large demand for effective therapies for chronic diseases as those involving the pancreas (diabetes), liver and heart; and (2) development of regenerative technologies related to therapies for these diseases is among the most advanced among all gene and cell therapy-based developments.

Over the next few years, additional significant growth in cell/tissue technologies will be for treatment of dental decay and disease. The growth rate expected here is roughly 21%. Several technologies in this segment, such as bone and tissue grafts, are already being marketed, but rather but rather than hitting a plateau, growth in this segment expected to be sustained by an aging population that will result in an increase in the numbers of people who can benefit from these therapies.

More Read

Hospitals No Longer Non-Profit?
Telemedicine Marketing Strategies: Building Thought Leadership
The (Little) Things That Matter To Patients
The Benefits of Medical Consultation Online
Why the TD2 DEEP 6 AI Partnership Is Good for Your Hospital

Applications of regenerative medicine in cardiology and vascular medicine will also show rapid adoptions in clinical practice over the next decade. These include treatments of coronary artery disease, myocardial infarction, congestive heart failure, dysfunctional heart valves, peripheral vascular disorders, and abdominal aortic aneurysms.  Growth in the adoption of these treatments, reflected in manufacturer revenues, will demonstrate compound annual growth rate of roughtly 20% from 2009 to 2018, is expected to result from commercialization of several innovative therapies that are expected to reach regulatory approval status.


Drawn from Report #S520, “Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.” MedMarket Diligence, LLC.

     

TAGGED:cell therapytissue engineering
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: Healthcare volunteer communication as a two-way, coordinator-supported process for confirming schedu
How to Manage Volunteer Communication in Healthcare: 5 Tactical Steps and Software Options
Global Healthcare
November 18, 2026
The Nervous System Reset Guide: Simple Ways To Manage Stress -- AI-generated illustration
The Nervous System Reset Guide: Simple Ways To Manage Stress
Infographics Mental Health
November 14, 2026
Flat editorial illustration: A single digital quality-management platform connects document control, electronic approval, audit r
6 Best QMS Software Platforms for ISO 13485 and FDA Part 820 (QMSR)
Global Healthcare Policy & Law
November 12, 2026
Flat editorial illustration: Healthcare editorial illustration about accurate patient intake connecting registration, clinical re
The Role of Patient Data Accuracy in Healthcare Operations
Global Healthcare Policy & Law
November 11, 2026

You Might also Like

physician wellness
BusinessHospital AdministrationMedical EducationWellness

Physician Wellness: Why It’s Such a Struggle

March 26, 2013

New Test For Prostate Cancer Is More Specific and Reduces False-Positives

May 16, 2011
NewsWellness

Is Genetics Behind Your Motivation to Exercise?

September 18, 2017

How States Waste Medicaid Dollars

May 12, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?